3117 Anticoagulation-associated-intracerebral hemorrhage treatment and outcomes analysed by the potential availability of specific versus non-specific reversal agents: a retrospective cohort study

• Stephen Bacchi,
• Timothy Kleinig,
• Siqi Chen,
• Jim Jannes,
• Brandon Stretton,
• Rudy Goh,
• Andrew Moey,
• Christopher Ovenden,
• Shaddy El-Masri,
• Lachlan Tamlin,
• Nicola Sulley-Beales,
• Sarah Howson,
• Daniel Zweck,
• Matthew Willcourt

Affiliations

Stephen Bacchi

Royal Adelaide Hospital, Adelaide, South Australia, Australia

Timothy Kleinig

Royal Adelaide Hospital, Adelaide, South Australia, Australia

Siqi Chen

Department of Medicine; Hematology/Oncology Division, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA

Jim Jannes

Royal Adelaide Hospital, Adelaide, South Australia, Australia

Brandon Stretton

medical practitioner

Rudy Goh

1Neurology, Royal Adelaide Hospital, Adelaide, SA, Australia

Andrew Moey

1Univeristy of Adelaide, Adelaide, SA, Australia

Christopher Ovenden

2Neurosurgery, Royal Adelaide Hospital, Adelaide, SA, Australia

Shaddy El-Masri

1Medicine, Royal Melbourne Hospital, Melbourne, VIC, Australia

Lachlan Tamlin

2Royal Adelaide Hospital, Adelaide, SA, Australia

Nicola Sulley-Beales

2Neurology, The Royal Adelaide Hospital, Adelaide, SA, Australia

Sarah Howson

2Neurology, The Royal Adelaide Hospital, Adelaide, SA, Australia

Daniel Zweck

2Neurology, The Royal Adelaide Hospital, Adelaide, SA, Australia

Matthew Willcourt

1Flinders Medical Centre, Adelaide, SA, Australia